{
    "Trade/Device Name(s)": [
        "Genesis Health Technologies Blood Glucose Monitoring System",
        "Genesis Health Technologies control solutions",
        "Genesis Health Technologies test strips"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K121224",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101631"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "LFR",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "August 14, 2012",
    "Summary Letter Received Date": "August 23, 2012",
    "Submission Date": "April 20, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Genesis Health Technologies Blood Glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology",
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Genesis Health Technologies Blood Glucose Monitoring System model TD-4123 for quantitative measurement of glucose in capillary blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from finger, palm, forearm, and upper arm as an aid to monitoring diabetes control at home; not for diagnosis or neonatal use; for single-user only",
    "fda_folder": "Clinical Chemistry"
}